|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.72 HKD | +0.86% |
|
-.--% | +34.48% |
| 06-26 | SciClone Pharmaceuticals Limited Announces Retirement of Wang Haixia as Non-Executive Director | CI |
| 06-21 | SciClone Pharmaceuticals Limited(SEHK:6600) dropped from S&P Global BMI Index | CI |
SciClone Pharmaceuticals, Inc. provided earnings guidance for 2013. The company anticipates 2013 sales revenue of $150 million - $155 million. The company expects 2013 non-GAAP EPS of $0.66 - $0.72 per share.
The company's non-GAAP EPS excludes employee stock-based compensation from GAAP EPS.
| 1st Jan change | Capi. | |
|---|---|---|
| +34.48% | 1.46B | |
| +7.46% | 100B | |
| +11.97% | 42.34B | |
| -12.43% | 32.76B | |
| +79.34% | 29.46B | |
| -12.45% | 16.31B | |
| +2.55% | 14.39B | |
| -1.90% | 12.23B | |
| +178.17% | 10.47B | |
| +1.80% | 8.97B |
SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED 
